The Duke Division of Hematologic Malignancies & Cellular Therapy is internationally recognized for its novel approaches to treating leukemia, lymphoma, myeloma, and other life threatening diseases through integrated, innovative, and holistic patient care, research, and education.

The mission of the Duke Division of Hematologic Malignancies and Cellular Therapy is to promote health and improve lives by preventing, diagnosing, and treating blood cancer and other life threatening diseases through integrated, innovative, and holistic patient care, education, and research.

Patient receiving treatment

Excellence in Patient Care

Our faculty provide comprehensive, multidisciplinary care for patients with hematologic malignancies at the Duke Cancer Center and the Duke Adult Blood & Marrow Transplant Clinic.

Stefanie in Lab

Excellence in Research

The Duke Hematologic Malignancies and Cellular Therapy (HMCT) Program is a multidisciplinary basic, translational, and clinical research program whose overall goal is to improve outcomes for patients with hematologic malignancies. 

Provider with patient

Train with us

The Hematology-Oncology Fellowship program provides clinical and laboratory training in hematology, medical oncology, and bone marrow transplantation.